Clinical Trials Logo
  1. Home
  2. Beta Thalassemia Major
  3. NCT02744560

Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C

Beta Thalassemia Major Clinical Trial

Official title:
Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C

Clinical Trial Summary

Thalassemics can develop liver fibrosis because of iron overload and hepatitis C infection. The latter is the main risk factor for liver fibrosis in transfusion dependent thalassemics. Excess liver iron is clearly recognized as a co factor for the development of advanced fibrosis in patients with hepatitis virus C infection. Magnetic resonance imaging represents the most available noninvasive technique to assess the level of iron in the liver.there is evidence that suggests Spirulina may help to protect against liver damage, cirrhosis and liver failure in those with chronic liver disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02744560
Study type Interventional
Source Tanta University
Contact
Status Completed
Phase N/A
Start date March 2015
Completion date December 2017
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03276455 - Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified Phase 1/Phase 2
Completed NCT02674607 - the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children N/A
Terminated NCT01571635 - Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia. Phase 2
Completed NCT04092205 - Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation Phase 2
Recruiting NCT06466304 - Inspiratory Muscle Training in Children With Beta Thalasemia N/A
Recruiting NCT04353986 - PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders Phase 3
Not yet recruiting NCT02173951 - An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients Phase 2/Phase 3
Completed NCT03947632 - Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia
Withdrawn NCT04776850 - Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies Early Phase 1
Completed NCT02744547 - Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C N/A
Completed NCT02744105 - Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C N/A
Active, not recruiting NCT03101423 - Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism N/A
Completed NCT02671695 - Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia N/A
Completed NCT00658385 - Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major N/A